SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biocept Inc. – ‘10-Q’ for 3/31/22 – ‘XML’

On:  Monday, 5/23/22, at 2:42pm ET   ·   For:  3/31/22   ·   Accession #:  1564590-22-20962   ·   File #:  1-36284

Previous ‘10-Q’:  ‘10-Q/A’ on 2/15/22 for 9/30/21   ·   Next:  ‘10-Q’ on 11/10/22 for 6/30/22   ·   Latest:  ‘10-Q’ on 8/14/23 for 6/30/23   ·   25 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/23/22  Biocept Inc.                      10-Q        3/31/22   69:8.2M                                   ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    940K 
 2: EX-10.1     Material Contract                                   HTML    262K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
12: R1          Document and Entity Information                     HTML     74K 
13: R2          Condensed Balance Sheets                            HTML    114K 
14: R3          Condensed Balance Sheets (Parenthetical)            HTML     39K 
15: R4          Condensed Statements of Operations and              HTML     96K 
                Comprehensive Loss (Unaudited)                                   
16: R5          Condensed Statements of Shareholders' Equity        HTML     61K 
17: R6          Condensed Statements of Cash Flows (Unaudited)      HTML     90K 
18: R7          Condensed Statements of Cash Flows (Unaudited)      HTML     26K 
                (Parenthetical)                                                  
19: R8          The Company, Business Activities and Basis of       HTML    121K 
                Presentation                                                     
20: R9          Liquidity                                           HTML     27K 
21: R10         Sales of Equity Securities                          HTML     29K 
22: R11         Fair Value Measurement                              HTML     35K 
23: R12         Balance Sheet Details                               HTML    104K 
24: R13         Leases                                              HTML    177K 
25: R14         Stock-Based Compensation                            HTML     95K 
26: R15         Common Stock Warrants Outstanding                   HTML     66K 
27: R16         Net Loss per Common Share                           HTML     46K 
28: R17         Commitments and Contingencies                       HTML     25K 
29: R18         Related Party Transactions                          HTML     25K 
30: R19         Subsequent Events                                   HTML     23K 
31: R20         The Company, Business Activities and Basis of       HTML    127K 
                Presentation (Policies)                                          
32: R21         The Company, Business Activities and Basis of       HTML     94K 
                Presentation (Tables)                                            
33: R22         Fair Value Measurement (Tables)                     HTML     29K 
34: R23         Balance Sheet Details (Tables)                      HTML    103K 
35: R24         Leases (Tables)                                     HTML    177K 
36: R25         Stock-Based Compensation (Tables)                   HTML     96K 
37: R26         Common Stock Warrants Outstanding (Tables)          HTML     63K 
38: R27         Net Loss per Common Share (Tables)                  HTML     45K 
39: R28         The Company, Business Activities and Basis of       HTML     46K 
                Presentation - Additional Information (Detail)                   
40: R29         The Company, Business Activities and Basis of       HTML     39K 
                Presentation - Composition of Net Revenues                       
                Recognized Disaggregated by Source (Detail)                      
41: R30         The Company, Business Activities and Basis of       HTML     34K 
                Presentation - Composition of Net Revenues                       
                Recognized Disaggregated by Nature (Detail)                      
42: R31         The Company, Business Activities and Basis of       HTML     39K 
                Presentation - Summary of Third-Party Payers That                
                Represent More Than 10% of Total Net Revenues and                
                Total Net Accounts Receivable and Their Related                  
                Percentage (Detail)                                              
43: R32         Liquidity - Additional Information (Detail)         HTML     53K 
44: R33         Sales of Equity Securities - Additional             HTML     66K 
                Information (Detail)                                             
45: R34         Fair Value Measurement - Additional Information     HTML     53K 
                (Detail)                                                         
46: R35         Fair Value Measurement - Assumptions Used for       HTML     38K 
                Determining Fair Values of Common Stock Warrants                 
                (Detail)                                                         
47: R36         Balance Sheet Details - Schedule of Fixed Assets    HTML     68K 
                and Accrued Liabilities (Detail)                                 
48: R37         Leases - Additional Information (Detail)            HTML    122K 
49: R38         Leases - Schedule of Right-Of-Use Lease Assets      HTML     26K 
                (Detail)                                                         
50: R39         Leases - Schedule of Current Portion of Operating   HTML     27K 
                and Finance Lease Liabilities (Detail)                           
51: R40         Leases - Schedule of Long-Term Portion of           HTML     27K 
                Operating and Finance Lease Liabilities (Detail)                 
52: R41         Leases - Schedule of Lease Expense (Detail)         HTML     30K 
53: R42         Leases - Schedule of Remaining Future Minimum       HTML     71K 
                Lease Payments for Finance and Operating Leases                  
                (Detail)                                                         
54: R43         Leases - Supplemental Cash Flow Information         HTML     28K 
                Related to Operating and Finance Leases (Detail)                 
55: R44         Stock-Based Compensation - Additional Information   HTML     73K 
                (Detail)                                                         
56: R45         Stock-Based Compensation - Summary of Stock Option  HTML     46K 
                Activity (Detail)                                                
57: R46         Stock-Based Compensation - Assumptions Used for     HTML     40K 
                Determining Fair Value of Stock Options Under                    
                Black-Scholes Pricing Model (Detail)                             
58: R47         Stock-Based Compensation - Effects of Stock-Based   HTML     34K 
                Compensation Related to Equity Awards to Employees               
                and Nonemployees on Condensed Statement of                       
                Operations and Comprehensive Loss (Detail)                       
59: R48         Common Stock Warrants Outstanding - Summary of      HTML     28K 
                Equity-Classified Common Stock Warrant Activity                  
                (Detail)                                                         
60: R49         Common Stock Warrants Outstanding - Additional      HTML     40K 
                Information (Detail)                                             
61: R50         Net Loss per Common Share - Additional Information  HTML     27K 
                (Detail)                                                         
62: R51         Net Loss per Common Share - Schedule of             HTML     34K 
                Anti-Dilutive Securities Excluded from                           
                Computations of Diluted Weighted-Average Shares                  
                (Detail)                                                         
63: R52         Commitments and Contingencies - Additional          HTML     29K 
                Information (Detail)                                             
64: R53         Related Party Transactions - Additional             HTML     29K 
                Information (Detail)                                             
67: XML         IDEA XML File -- Filing Summary                      XML    123K 
65: XML         XBRL Instance -- bioc-10q_20220331_htm               XML   1.68M 
66: EXCEL       IDEA Workbook of Financial Reports                  XLSX     78K 
 8: EX-101.CAL  XBRL Calculations -- bioc-20220331_cal               XML    162K 
 9: EX-101.DEF  XBRL Definitions -- bioc-20220331_def                XML    429K 
10: EX-101.LAB  XBRL Labels -- bioc-20220331_lab                     XML   1.17M 
11: EX-101.PRE  XBRL Presentations -- bioc-20220331_pre              XML    817K 
 7: EX-101.SCH  XBRL Schema -- bioc-20220331                         XSD    188K 
68: JSON        XBRL Instance as JSON Data -- MetaLinks              342±   517K 
69: ZIP         XBRL Zipped Folder -- 0001564590-22-020962-xbrl      Zip    276K

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.22.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 151 </ContextCount>
<ElementCount> 297 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> true </FootnotesReported>
<SegmentCount> 61 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 6 </UnitCount>
<MyReports>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 100000 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 100010 - Statement - Condensed Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/StatementCondensedBalanceSheets </Role>
<ShortName> Condensed Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 100020 - Statement - Condensed Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/StatementCondensedBalanceSheetsParenthetical </Role>
<ShortName> Condensed Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 100030 - Statement - Condensed Statements of Operations and Comprehensive Loss (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/StatementCondensedStatementsOfOperationsAndComprehensiveLossUnaudited </Role>
<ShortName> Condensed Statements of Operations and Comprehensive Loss (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 100040 - Statement - Condensed Statements of Shareholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/StatementCondensedStatementsOfShareholdersEquity </Role>
<ShortName> Condensed Statements of Shareholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 100050 - Statement - Condensed Statements of Cash Flows (Unaudited) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/StatementCondensedStatementsOfCashFlowsUnaudited </Role>
<ShortName> Condensed Statements of Cash Flows (Unaudited) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 100060 - Statement - Condensed Statements of Cash Flows (Unaudited) (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/StatementCondensedStatementsOfCashFlowsUnauditedParenthetical </Role>
<ShortName> Condensed Statements of Cash Flows (Unaudited) (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 100070 - Disclosure - The Company, Business Activities and Basis of Presentation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentation </Role>
<ShortName> The Company, Business Activities and Basis of Presentation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 100080 - Disclosure - Liquidity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLiquidity </Role>
<ShortName> Liquidity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 100090 - Disclosure - Sales of Equity Securities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureSalesOfEquitySecurities </Role>
<ShortName> Sales of Equity Securities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 100100 - Disclosure - Fair Value Measurement </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureFairValueMeasurement </Role>
<ShortName> Fair Value Measurement </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 100110 - Disclosure - Balance Sheet Details </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureBalanceSheetDetails </Role>
<ShortName> Balance Sheet Details </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 100120 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 100130 - Disclosure - Stock-Based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureStockBasedCompensation </Role>
<ShortName> Stock-Based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 100140 - Disclosure - Common Stock Warrants Outstanding </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureCommonStockWarrantsOutstanding </Role>
<ShortName> Common Stock Warrants Outstanding </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 100150 - Disclosure - Net Loss per Common Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureNetLossPerCommonShare </Role>
<ShortName> Net Loss per Common Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 100160 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureCommitmentsAndContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 100170 - Disclosure - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureRelatedPartyTransactions </Role>
<ShortName> Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 100180 - Disclosure - Subsequent Events </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureSubsequentEvents </Role>
<ShortName> Subsequent Events </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 100190 - Disclosure - The Company, Business Activities and Basis of Presentation (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationPolicies </Role>
<ShortName> The Company, Business Activities and Basis of Presentation (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 100200 - Disclosure - The Company, Business Activities and Basis of Presentation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationTables </Role>
<ShortName> The Company, Business Activities and Basis of Presentation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentation </ParentRole>
<Position> 21 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 100210 - Disclosure - Fair Value Measurement (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureFairValueMeasurementTables </Role>
<ShortName> Fair Value Measurement (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220331/taxonomy/role/DisclosureFairValueMeasurement </ParentRole>
<Position> 22 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 100220 - Disclosure - Balance Sheet Details (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureBalanceSheetDetailsTables </Role>
<ShortName> Balance Sheet Details (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220331/taxonomy/role/DisclosureBalanceSheetDetails </ParentRole>
<Position> 23 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 100230 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeases </ParentRole>
<Position> 24 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 100240 - Disclosure - Stock-Based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureStockBasedCompensationTables </Role>
<ShortName> Stock-Based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220331/taxonomy/role/DisclosureStockBasedCompensation </ParentRole>
<Position> 25 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 100250 - Disclosure - Common Stock Warrants Outstanding (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureCommonStockWarrantsOutstandingTables </Role>
<ShortName> Common Stock Warrants Outstanding (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220331/taxonomy/role/DisclosureCommonStockWarrantsOutstanding </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 100260 - Disclosure - Net Loss per Common Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureNetLossPerCommonShareTables </Role>
<ShortName> Net Loss per Common Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biocept.com/20220331/taxonomy/role/DisclosureNetLossPerCommonShare </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 100270 - Disclosure - The Company, Business Activities and Basis of Presentation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationAdditionalInformationDetail </Role>
<ShortName> The Company, Business Activities and Basis of Presentation - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 100280 - Disclosure - The Company, Business Activities and Basis of Presentation - Composition of Net Revenues Recognized Disaggregated by Source (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationCompositionOfNetRevenuesRecognizedDisaggregatedBySourceDetail </Role>
<ShortName> The Company, Business Activities and Basis of Presentation - Composition of Net Revenues Recognized Disaggregated by Source (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 100290 - Disclosure - The Company, Business Activities and Basis of Presentation - Composition of Net Revenues Recognized Disaggregated by Nature (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationCompositionOfNetRevenuesRecognizedDisaggregatedByNatureDetail </Role>
<ShortName> The Company, Business Activities and Basis of Presentation - Composition of Net Revenues Recognized Disaggregated by Nature (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 100300 - Disclosure - The Company, Business Activities and Basis of Presentation - Summary of Third-Party Payers That Represent More Than 10% of Total Net Revenues and Total Net Accounts Receivable and Their Related Percentage (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureTheCompanyBusinessActivitiesAndBasisOfPresentationSummaryOfThirdPartyPayersThatRepresentMoreThan10OfTotalNetRevenuesAndTotalNetAccountsReceivableAndTheirRelatedPercentageDetail </Role>
<ShortName> The Company, Business Activities and Basis of Presentation - Summary of Third-Party Payers That Represent More Than 10% of Total Net Revenues and Total Net Accounts Receivable and Their Related Percentage (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 31 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 100310 - Disclosure - Liquidity - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLiquidityAdditionalInformationDetail </Role>
<ShortName> Liquidity - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 100320 - Disclosure - Sales of Equity Securities - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureSalesOfEquitySecuritiesAdditionalInformationDetail </Role>
<ShortName> Sales of Equity Securities - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 33 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 100330 - Disclosure - Fair Value Measurement - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureFairValueMeasurementAdditionalInformationDetail </Role>
<ShortName> Fair Value Measurement - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 34 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 100340 - Disclosure - Fair Value Measurement - Assumptions Used for Determining Fair Values of Common Stock Warrants (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureFairValueMeasurementAssumptionsUsedForDeterminingFairValuesOfCommonStockWarrantsDetail </Role>
<ShortName> Fair Value Measurement - Assumptions Used for Determining Fair Values of Common Stock Warrants (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 35 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 100350 - Disclosure - Balance Sheet Details - Schedule of Fixed Assets and Accrued Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureBalanceSheetDetailsScheduleOfFixedAssetsAndAccruedLiabilitiesDetail </Role>
<ShortName> Balance Sheet Details - Schedule of Fixed Assets and Accrued Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 36 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 100360 - Disclosure - Leases - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesAdditionalInformationDetail </Role>
<ShortName> Leases - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 37 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 100370 - Disclosure - Leases - Schedule of Right-Of-Use Lease Assets (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesScheduleOfRightOfUseLeaseAssetsDetail </Role>
<ShortName> Leases - Schedule of Right-Of-Use Lease Assets (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 38 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 100380 - Disclosure - Leases - Schedule of Current Portion of Operating and Finance Lease Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesScheduleOfCurrentPortionOfOperatingAndFinanceLeaseLiabilitiesDetail </Role>
<ShortName> Leases - Schedule of Current Portion of Operating and Finance Lease Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 39 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 100390 - Disclosure - Leases - Schedule of Long-Term Portion of Operating and Finance Lease Liabilities (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesScheduleOfLongTermPortionOfOperatingAndFinanceLeaseLiabilitiesDetail </Role>
<ShortName> Leases - Schedule of Long-Term Portion of Operating and Finance Lease Liabilities (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 40 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 100400 - Disclosure - Leases - Schedule of Lease Expense (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesScheduleOfLeaseExpenseDetail </Role>
<ShortName> Leases - Schedule of Lease Expense (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 41 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 100410 - Disclosure - Leases - Schedule of Remaining Future Minimum Lease Payments for Finance and Operating Leases (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesScheduleOfRemainingFutureMinimumLeasePaymentsForFinanceAndOperatingLeasesDetail </Role>
<ShortName> Leases - Schedule of Remaining Future Minimum Lease Payments for Finance and Operating Leases (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 100430 - Disclosure - Leases - Supplemental Cash Flow Information Related to Operating and Finance Leases (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureLeasesSupplementalCashFlowInformationRelatedToOperatingAndFinanceLeasesDetail </Role>
<ShortName> Leases - Supplemental Cash Flow Information Related to Operating and Finance Leases (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 100440 - Disclosure - Stock-Based Compensation - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail </Role>
<ShortName> Stock-Based Compensation - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 44 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 100450 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetail </Role>
<ShortName> Stock-Based Compensation - Summary of Stock Option Activity (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 100460 - Disclosure - Stock-Based Compensation - Assumptions Used for Determining Fair Value of Stock Options Under Black-Scholes Pricing Model (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureStockBasedCompensationAssumptionsUsedForDeterminingFairValueOfStockOptionsUnderBlackScholesPricingModelDetail </Role>
<ShortName> Stock-Based Compensation - Assumptions Used for Determining Fair Value of Stock Options Under Black-Scholes Pricing Model (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 46 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 100470 - Disclosure - Stock-Based Compensation - Effects of Stock-Based Compensation Related to Equity Awards to Employees and Nonemployees on Condensed Statement of Operations and Comprehensive Loss (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureStockBasedCompensationEffectsOfStockBasedCompensationRelatedToEquityAwardsToEmployeesAndNonemployeesOnCondensedStatementOfOperationsAndComprehensiveLossDetail </Role>
<ShortName> Stock-Based Compensation - Effects of Stock-Based Compensation Related to Equity Awards to Employees and Nonemployees on Condensed Statement of Operations and Comprehensive Loss (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 47 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 100480 - Disclosure - Common Stock Warrants Outstanding - Summary of Equity-Classified Common Stock Warrant Activity (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureCommonStockWarrantsOutstandingSummaryOfEquityClassifiedCommonStockWarrantActivityDetail </Role>
<ShortName> Common Stock Warrants Outstanding - Summary of Equity-Classified Common Stock Warrant Activity (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 48 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 100490 - Disclosure - Common Stock Warrants Outstanding - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureCommonStockWarrantsOutstandingAdditionalInformationDetail </Role>
<ShortName> Common Stock Warrants Outstanding - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 100500 - Disclosure - Net Loss per Common Share - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformationDetail </Role>
<ShortName> Net Loss per Common Share - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 100510 - Disclosure - Net Loss per Common Share - Schedule of Anti-Dilutive Securities Excluded from Computations of Diluted Weighted-Average Shares (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfAntiDilutiveSecuritiesExcludedFromComputationsOfDilutedWeightedAverageSharesDetail </Role>
<ShortName> Net Loss per Common Share - Schedule of Anti-Dilutive Securities Excluded from Computations of Diluted Weighted-Average Shares (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 51 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 100520 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail </Role>
<ShortName> Commitments and Contingencies - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 52 </Position>
</Report>
<Report instance="bioc-10q_20220331.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 100530 - Disclosure - Related Party Transactions - Additional Information (Detail) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biocept.com/20220331/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail </Role>
<ShortName> Related Party Transactions - Additional Information (Detail) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 53 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="bioc-10q_20220331.htm"> bioc-10q_20220331.htm </File>
<File> bioc-20220331.xsd </File>
<File> bioc-20220331_cal.xml </File>
<File> bioc-20220331_def.xml </File>
<File> bioc-20220331_lab.xml </File>
<File> bioc-20220331_pre.xml </File>
<File> bioc-ex101_201.htm </File>
<File> bioc-ex311_8.htm </File>
<File> bioc-ex312_9.htm </File>
<File> bioc-ex321_6.htm </File>
<File> bioc-ex322_7.htm </File>
</InputFiles>
<SupplementalFiles/>
<BaseTaxonomies>
<BaseTaxonomy items="1"> http://fasb.org/srt/2021-01-31 </BaseTaxonomy>
<BaseTaxonomy items="436"> http://fasb.org/us-gaap/2021-01-31 </BaseTaxonomy>
<BaseTaxonomy items="29"> http://xbrl.sec.gov/dei/2021q4 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

25 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/05/22  Biocept Inc.                      10-K       12/31/21   88:13M                                    ActiveDisclosure/FA
 3/24/22  Biocept Inc.                      8-K:5,9     3/22/22   11:148K                                   Donnelley … Solutions/FA
 3/08/22  Biocept Inc.                      8-K:5,9     3/08/22   11:214K                                   Donnelley … Solutions/FA
 2/16/22  Biocept Inc.                      8-K:5,9     2/15/22   12:289K                                   Donnelley … Solutions/FA
11/16/20  Biocept Inc.                      10-Q        9/30/20   70:8.7M                                   ActiveDisclosure/FA
 9/04/20  Biocept Inc.                      8-K:3,5,9   9/03/20    2:62K                                    ActiveDisclosure/FA
 1/09/20  Biocept Inc.                      8-K:1,3,9   1/09/20    3:284K                                   ActiveDisclosure/FA
12/11/19  Biocept Inc.                      8-K:8,9    12/09/19    4:290K                                   ActiveDisclosure/FA
12/06/19  Biocept Inc.                      S-1/A                  3:816K                                   ActiveDisclosure/FA
 5/29/19  Biocept Inc.                      8-K:1,3,9   5/28/19    3:273K                                   ActiveDisclosure/FA
 3/18/19  Biocept Inc.                      8-K:1,3,8,9 3/15/19    6:670K                                   ActiveDisclosure/FA
11/28/18  Biocept Inc.                      S-1                    4:827K                                   ActiveDisclosure/FA
 9/24/18  Biocept Inc.                      8-K:1,3,8,9 9/20/18    7:830K                                   ActiveDisclosure/FA
 8/13/18  Biocept Inc.                      8-K:3,5,8,9 8/09/18    3:463K                                   ActiveDisclosure/FA
 7/11/18  Biocept Inc.                      S-1/A                 15:3.6M                                   Donnelley … Solutions/FA
 7/06/18  Biocept Inc.                      8-K:3,5,9   7/06/18    2:57K                                    ActiveDisclosure/FA
 1/30/18  Biocept Inc.                      8-K:8,9     1/30/18    2:161K                                   ActiveDisclosure/FA
 1/22/18  Biocept Inc.                      S-1/A                 86:9.1M                                   Donnelley … Solutions/FA
 9/29/17  Biocept Inc.                      8-K:5,9     9/27/17    2:49K                                    ActiveDisclosure/FA
 8/10/17  Biocept Inc.                      8-K:1,3,9   8/09/17    3:333K                                   ActiveDisclosure/FA
 3/30/17  Biocept Inc.                      8-K:1,3,8,9 3/28/17    7:627K                                   ActiveDisclosure/FA
 9/29/16  Biocept Inc.                      8-K:5,8,9   9/27/16    3:319K                                   ActiveDisclosure/FA
 5/06/14  Biocept Inc.                      8-K:1,2,3,9 4/30/14    3:366K                                   Donnelley … Solutions/FA
 2/14/14  Biocept Inc.                      8-K:1,3,5,8 2/10/14    3:368K                                   Donnelley … Solutions/FA
 9/23/13  Biocept Inc.                      S-1¶                  71:6.2M                                   Donnelley … Solutions/FA
↑Top
Filing Submission 0001564590-22-020962   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Wed., May 15, 8:42:34.3pm ET